InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Sunday, 11/25/2018 8:20:17 AM

Sunday, November 25, 2018 8:20:17 AM

Post# of 403079
So much focus on EOP2 meeting - in reality the FDA just discusses P3 and protocol and many times suggest that the co will need 2 P3 trials to apply for NDA. I believe that killed ABSSI P3 plans and went on shelf.

The trial size for B- OM trial could kill the deal - the enrolling timeline from previous trial and fact that P3 trial needs many more patient could mean this will be a 2+ year trial and if a confirmatory trial is needed then the partnership is doomed and IPIX will get peanuts if at all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News